36 related articles for article (PubMed ID: 10187841)
1. Kinetic analysis of the binding of hemopexin-like domain of gelatinase B cloned and expressed in Pichia pastoris to tissue inhibitor of metalloproteinases-1.
Stute J; Pourmotabbed T; Tschesche H
J Protein Chem; 2003 Aug; 22(6):509-14. PubMed ID: 14703983
[TBL] [Abstract][Full Text] [Related]
2. Expression and Purification of Active Monomeric MMP7.
Yamamoto K; Isohata M; Higashi S
Methods Mol Biol; 2024; 2747():67-73. PubMed ID: 38038932
[TBL] [Abstract][Full Text] [Related]
3. The Biology and Function of Tissue Inhibitor of Metalloproteinase 2 in the Lungs.
Costanzo L; Soto B; Meier R; Geraghty P
Pulm Med; 2022; 2022():3632764. PubMed ID: 36624735
[TBL] [Abstract][Full Text] [Related]
4. Thermodynamic Basis of Selectivity in the Interactions of Tissue Inhibitors of Metalloproteinases N-domains with Matrix Metalloproteinases-1, -3, and -14.
Zou H; Wu Y; Brew K
J Biol Chem; 2016 May; 291(21):11348-58. PubMed ID: 27033700
[TBL] [Abstract][Full Text] [Related]
5. Carbamylation of immunoglobulin abrogates activation of the classical complement pathway.
Koro C; Bielecka E; Dahl-Knudsen A; Enghild JJ; Scavenius C; Brun JG; Binder V; Hellvard A; Bergum B; Jonsson R; Potempa J; Blom AM; Mydel P
Eur J Immunol; 2014 Nov; 44(11):3403-12. PubMed ID: 25130613
[TBL] [Abstract][Full Text] [Related]
6. Autoantibodies to posttranslational modifications in rheumatoid arthritis.
Burska AN; Hunt L; Boissinot M; Strollo R; Ryan BJ; Vital E; Nissim A; Winyard PG; Emery P; Ponchel F
Mediators Inflamm; 2014; 2014():492873. PubMed ID: 24782594
[TBL] [Abstract][Full Text] [Related]
7. Endogenous carbamylation of renal medullary proteins.
Claxton JS; Sandoval PC; Liu G; Chou CL; Hoffert JD; Knepper MA
PLoS One; 2013; 8(12):e82655. PubMed ID: 24386107
[TBL] [Abstract][Full Text] [Related]
8. Molecular design of a highly selective and strong protein inhibitor against matrix metalloproteinase-2 (MMP-2).
Higashi S; Hirose T; Takeuchi T; Miyazaki K
J Biol Chem; 2013 Mar; 288(13):9066-76. PubMed ID: 23395821
[TBL] [Abstract][Full Text] [Related]
9. TIMP-2 fusion protein with human serum albumin potentiates anti-angiogenesis-mediated inhibition of tumor growth by suppressing MMP-2 expression.
Lee MS; Jung JI; Kwon SH; Lee SM; Morita K; Her S
PLoS One; 2012; 7(4):e35710. PubMed ID: 22545131
[TBL] [Abstract][Full Text] [Related]
10. Dynamic interdomain interactions contribute to the inhibition of matrix metalloproteinases by tissue inhibitors of metalloproteinases.
Remacle AG; Shiryaev SA; Radichev IA; Rozanov DV; Stec B; Strongin AY
J Biol Chem; 2011 Jun; 286(23):21002-12. PubMed ID: 21518756
[TBL] [Abstract][Full Text] [Related]
11. Entropy increases from different sources support the high-affinity binding of the N-terminal inhibitory domains of tissue inhibitors of metalloproteinases to the catalytic domains of matrix metalloproteinases-1 and -3.
Wu Y; Wei S; Van Doren SR; Brew K
J Biol Chem; 2011 May; 286(19):16891-9. PubMed ID: 21454617
[TBL] [Abstract][Full Text] [Related]
12. Reactive-site mutants of N-TIMP-3 that selectively inhibit ADAMTS-4 and ADAMTS-5: biological and structural implications.
Lim NH; Kashiwagi M; Visse R; Jones J; Enghild JJ; Brew K; Nagase H
Biochem J; 2010 Oct; 431(1):113-22. PubMed ID: 20645923
[TBL] [Abstract][Full Text] [Related]
13. Cholesterol sulfate alters substrate preference of matrix metalloproteinase-7 and promotes degradations of pericellular laminin-332 and fibronectin.
Yamamoto K; Miyazaki K; Higashi S
J Biol Chem; 2010 Sep; 285(37):28862-73. PubMed ID: 20605794
[TBL] [Abstract][Full Text] [Related]
14. Carbamylation-dependent activation of T cells: a novel mechanism in the pathogenesis of autoimmune arthritis.
Mydel P; Wang Z; Brisslert M; Hellvard A; Dahlberg LE; Hazen SL; Bokarewa M
J Immunol; 2010 Jun; 184(12):6882-90. PubMed ID: 20488785
[TBL] [Abstract][Full Text] [Related]
15. Progress in matrix metalloproteinase research.
Murphy G; Nagase H
Mol Aspects Med; 2008 Oct; 29(5):290-308. PubMed ID: 18619669
[TBL] [Abstract][Full Text] [Related]
16. Inactivation of N-TIMP-1 by N-terminal acetylation when expressed in bacteria.
Van Doren SR; Wei S; Gao G; DaGue BB; Palmier MO; Bahudhanapati H; Brew K
Biopolymers; 2008 Nov; 89(11):960-8. PubMed ID: 18615493
[TBL] [Abstract][Full Text] [Related]
17. Reactive site-modified tissue inhibitor of metalloproteinases-2 inhibits the cell-mediated activation of progelatinase A.
Higashi S; Miyazaki K
J Biol Chem; 1999 Apr; 274(15):10497-504. PubMed ID: 10187841
[TBL] [Abstract][Full Text] [Related]
18. Specific, high affinity binding of tissue inhibitor of metalloproteinases-4 (TIMP-4) to the COOH-terminal hemopexin-like domain of human gelatinase A. TIMP-4 binds progelatinase A and the COOH-terminal domain in a similar manner to TIMP-2.
Bigg HF; Shi YE; Liu YE; Steffensen B; Overall CM
J Biol Chem; 1997 Jun; 272(24):15496-500. PubMed ID: 9182583
[TBL] [Abstract][Full Text] [Related]
19. Tissue inhibitor of metalloproteinases-4 inhibits but does not support the activation of gelatinase A via efficient inhibition of membrane type 1-matrix metalloproteinase.
Bigg HF; Morrison CJ; Butler GS; Bogoyevitch MA; Wang Z; Soloway PD; Overall CM
Cancer Res; 2001 May; 61(9):3610-8. PubMed ID: 11325829
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
